From January 1, 2023 to March 31, 2023, the company has repurchased 24,399 shares, representing 0.2% for KRW 1,920.4 million. With this, the company has completed the repurchase of 37,238 shares, representing 0.31% for KRW 2,914.01 million under the buyback announced on October 13, 2022.
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
101,400 KRW | -1.74% | -0.49% | -22.54% |
EPS Revisions
Quarterly revenue - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-22.54% | 960M | |
+20.99% | 43.27B | |
+24.71% | 22.92B | |
+19.22% | 15.43B | |
+11.40% | 12.95B | |
+44.81% | 11.83B | |
-7.25% | 6.91B | |
-0.05% | 6.79B | |
-8.87% | 5.73B | |
+13.26% | 5.55B |
- Stock Market
- Equities
- A185750 Stock
- News Chong Kun Dang Pharmaceutical Corp.
- Tranche Update on Chong Kun Dang Pharmaceutical Corp.'s Equity Buyback Plan announced on October 13, 2022.